Skip to main content
Log in

The expression of receptors for vasoactive intestinal peptide and secretin in colon neoplasms

  • Clinical Observation
  • Published:
Chinese Journal of Cancer Research

Abstract

Objective: To investigate the expression of the receptors for vasoactive intestinal peptide (VIP) and secretin in colon cancer. Methods: This study visualized and characterized the receptors for VIP and secretin in the sequence of human tumor-free colon, adenoma, carcinoma, liver metastasis using storage phosphor autoradiography. Results: Receptors for VIP and secretin were demonstrated in tumor-free colon and colon tumors. A decrease in affinity of VIP receptors was shown in the colonic liver metastasis (Kd = 3.30 nmol) when compared with tumor-free colon (Kd = 0.82 nmol). An up-regulation of receptors for secretin was found in colonic liver metastases. Conclusions: VIP and secretin were both expressed on normal colon tissues. Binding of VIP decreased while secretin increased in colonic liver metastasis. A down-regulation of receptors for VIP in colonic liver metastases may helpful to understand the migration of colon cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Van Solinge WW, Nielsen FC, Friis-Hansen L, et al. Expression but incomplete maturation of progastrin in colorectal carcinomas[J]. Gastroenterology 1993; 104:1099.

    PubMed  Google Scholar 

  2. Frucht H, Gazdar AF, Park J-A, et al. Chracterization of functional receptors for gastrointestinal hormones on human colon cancer cells[J]. Cancer Res 1992; 52:1114.

    PubMed  CAS  Google Scholar 

  3. Fantini J, Martin J-M, Luis J, et al. Restricted localization of functional vasoactive intestinal peptide (VIP) receptors in in vitro differentiated human colonic adenocarcinoma cells (HT29-D4)[J]. Eur J Cell Biol 1988; 46:458.

    PubMed  CAS  Google Scholar 

  4. Virgolini I, Raderer M, Kurtaran A, et al. Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors[J]. New Eng J Med 1994; 331:1116.

    Article  PubMed  CAS  Google Scholar 

  5. Ensinck JW, Laschansky EC, Vogel RE, et al. Circulating prosomatostatin-derived peptides differential responses to food ingestion[J]. J Clin Invest 1989; 83:1580.

    Article  PubMed  CAS  Google Scholar 

  6. Schaffalitzky de Muckadell OB, and Fahrenkrug J. Preparation of 125I-labelled synthetic porcine secretin for radio-immunoassay[J]. Scand J Clin Lab Invest 1976; 36:661.

    CAS  Google Scholar 

  7. Tang C, Biemond I, Offerhaus GJA, Lamers CBHW. Expression of peptide receptors in human exocrine tumors of the pancreas[J]. Br J Cancer 1997; 75:1467.

    PubMed  CAS  Google Scholar 

  8. Chung D. Molecular prognostic markers and colorectal cancer: the search goes on[J]. Gastroenterol 1998; 114:1330.

    Article  CAS  Google Scholar 

  9. Martinez-López E, Abad A, Monzó M, et al. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer[J]. Gastroenterol 1998; 114:1180.

    Article  Google Scholar 

  10. Baldwin GS and Shulkes A. Gastrin, gastrin receptors and colorectal carcinoma[J]. Gut 1998; 42:581.

    Article  PubMed  CAS  Google Scholar 

  11. Couvineau A, Rousset M, LaBurthe M. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29[J]. Biochem J 1985; 231:139.

    PubMed  CAS  Google Scholar 

  12. Waschek JA. Vasoactive intestinal peptide: an important trophic factor and developmental regulator[J]. Dev Neurosci 1995; 17:1.

    PubMed  CAS  Google Scholar 

  13. Ogasawara m, Murata J, Ayukawa K, et al. differential effect of intestinal neuropeptides on invasion and migration of colon carcinoma cells in vitro[J]. Cancer Lett 1997; 116:111.

    Article  PubMed  CAS  Google Scholar 

  14. Tang C, Biemond I, Lamers CBHW. Localization and quantification of cholecystokinin receptors in rat brain with storage phosphor autoradiography. Bio Techniques 1995; 18:886.

    CAS  Google Scholar 

  15. Munson PJ, Rodbard D. LIGAND: Characterizations of binding systems: a versatile, computerized approach[J]. Anal Biochem 1980; 107:220.

    Article  PubMed  CAS  Google Scholar 

  16. Raderer M, Kurtaran A, Hejna M, et al. 123I-labelled vasoactive intestinal peptide receptor scintigraphy in patients with colorectal cancer[J]. Br J Cancer 1998; 78:1.

    PubMed  CAS  Google Scholar 

  17. Misbin RI, Wolfe MM, Morris P, et al. Uptake of vasoactive intestinal peptide by rat liver[J]. Am J Physiol 1982; 243:G103.

    Google Scholar 

  18. Ulrich CD, II Holtmann M, Miller LJ. Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors[J]. Gastroenterol 1998; 114:382.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tang Cheng-wei.

Additional information

Foundation item: This work was supported by a Grant from Chinese National Science Research Foundation of China for the Excellent Young Scientist(No. 39725012).

Biography: Tang cheng-wei, (1957–), doctor of medicine, professor, First Hospital, Chongqing University of Medical Sciences, majors in gastroenterological cancer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tang, Cw., Biemond, I., Verspaget, H.W. et al. The expression of receptors for vasoactive intestinal peptide and secretin in colon neoplasms. Chin. J. Cancer Res. 13, 280–283 (2001). https://doi.org/10.1007/s11670-001-0048-2

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11670-001-0048-2

Key words

CLC number

Navigation